---
title: "Madrigal Pharmaceuticals President, CEO Sold Shares Worth Over $1.3M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293269781.md"
description: "Madrigal Pharmaceuticals President and CEO William John Sibold sold shares worth over $1.3 million in automatic transactions to cover tax withholding for earned performance shares. The weighted-average sale prices ranged from $542.75 to $555.05 per share. Following these sales, Sibold directly beneficially owns 209,329 shares of common stock."
datetime: "2026-07-21T01:20:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293269781.md)
  - [en](https://longbridge.com/en/news/293269781.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293269781.md)
generator: "portal-rs"
---

# Madrigal Pharmaceuticals President, CEO Sold Shares Worth Over $1.3M

William John Sibold, a director and the President, CEO, sold shares in automatic transactions to cover tax withholding related to earned performance shares. The transactions reported a series of weighted-average prices per share ranging from $542.7459 to $555.05. The total sale amount reported across the transactions was $1,368,253. Following the reported transactions, Sibold directly beneficially owns 209,329 shares of common stock.

Reporter Name

Sibold William John

Relationship

President and CEO

Type

Sell

Amount

$1,368,253

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [MDGL.US](https://longbridge.com/en/quote/MDGL.US.md)

## Related News & Research

- [Madrigal Pharmaceuticals to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297782167.md)
- [Madrigal Pharma director John C. Reed files initial beneficial ownership statement](https://longbridge.com/en/news/296270622.md)
- [CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 3,000 common shares valued at $147](https://longbridge.com/en/news/297819057.md)
- [FedEx Incheon Gateway wins IATA CEIV Pharma certification](https://longbridge.com/en/news/297711873.md)
- [Jazz Pharma EVP Global Head of R&D and CMO Robert Iannone disposes of shares worth $19.23 million](https://longbridge.com/en/news/297568088.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**